Holme E - Search Results

1

Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1.

Bartlett DC, Preece MA, Holme E, Lloyd C, Newsome PN, McKiernan PJ. Bartlett DC, et al. Among authors: holme e. J Inherit Metab Dis. 2013 Jan;36(1):15-20. doi: 10.1007/s10545-012-9482-1. Epub 2012 Mar 29. J Inherit Metab Dis. 2013. PMID: 22456946

2

Outcome of tyrosinaemia type III.

Ellaway CJ, Holme E, Standing S, Preece MA, Green A, Ploechl E, Ugarte M, Trefz FK, Leonard JV. Ellaway CJ, et al. Among authors: holme e. J Inherit Metab Dis. 2001 Dec;24(8):824-32. doi: 10.1023/a:1013936107064. J Inherit Metab Dis. 2001. PMID: 11916315

3

Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.

Baumann U, Duhme V, Auth MK, McKiernan PJ, Holme E. Baumann U, et al. Among authors: holme e. J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):77-82. doi: 10.1097/01.mpg.0000228112.29359.f8. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819381

4

Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Holme E, Lindstedt S. Holme E, et al. J Inherit Metab Dis. 1998 Aug;21(5):507-17. doi: 10.1023/a:1005410820201. J Inherit Metab Dis. 1998. PMID: 9728331 Review.

5

NTBC as palliative treatment in chronic tyrosinaemia type I.

Ros J, Vilaseca MA, Lambruschini N, Mas A, Lindstedt S, Holme E. Ros J, et al. Among authors: holme e. J Inherit Metab Dis. 1999 Jun;22(5):665-6. doi: 10.1023/a:1005594416973. J Inherit Metab Dis. 1999. PMID: 10399099 No abstract available.

6

Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I.

Kim SZ, Kupke KG, Ierardi-Curto L, Holme E, Greter J, Tanguay RM, Poudrier J, D'Astous M, Lettre F, Hahn SH, Levy HL. Kim SZ, et al. Among authors: holme e. J Inherit Metab Dis. 2000 Dec;23(8):791-804. doi: 10.1023/a:1026756501669. J Inherit Metab Dis. 2000. PMID: 11196105

7

Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.

Riudor E, Ribes A, Lloret J, Friden J, Holme E, Jakobs C, Martinez Ibanez V. Riudor E, et al. Among authors: holme e. J Inherit Metab Dis. 1991;14(3):281-4. doi: 10.1007/BF01811682. J Inherit Metab Dis. 1991. PMID: 1770775 No abstract available.

8

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

Pronicka E, Rowinska E, Bentkowski Z, Zawadzki J, Holme E, Lindstedt S. Pronicka E, et al. Among authors: holme e. J Inherit Metab Dis. 1996;19(2):234-8. doi: 10.1007/BF01799438. J Inherit Metab Dis. 1996. PMID: 8739974 No abstract available.

9

Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.

Carrozzo R, Verrigni D, Rasmussen M, de Coo R, Amartino H, Bianchi M, Buhas D, Mesli S, Naess K, Born AP, Woldseth B, Prontera P, Batbayli M, Ravn K, Joensen F, Cordelli DM, Santorelli FM, Tulinius M, Darin N, Duno M, Jouvencel P, Burlina A, Stangoni G, Bertini E, Redonnet-Vernhet I, Wibrand F, Dionisi-Vici C, Uusimaa J, Vieira P, Osorio AN, McFarland R, Taylor RW, Holme E, Ostergaard E. Carrozzo R, et al. Among authors: holme e. J Inherit Metab Dis. 2016 Mar;39(2):243-52. doi: 10.1007/s10545-015-9894-9. Epub 2015 Oct 16. J Inherit Metab Dis. 2016. PMID: 26475597

10

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Lindstedt S, et al. Among authors: holme e. Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9. Lancet. 1992. PMID: 1383656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page